Arcadia Investment Management Corp Dyne Therapeutics, Inc. Transaction History
Arcadia Investment Management Corp
- $623 Million
- Q4 2024
A detailed history of Arcadia Investment Management Corp transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Arcadia Investment Management Corp holds 44,940 shares of DYN stock, worth $664,662. This represents 0.17% of its overall portfolio holdings.
Number of Shares
44,940
Previous 38,614
16.38%
Holding current value
$664,662
Previous $1.39 Million
23.72%
% of portfolio
0.17%
Previous 0.23%
Shares
4 transactions
Others Institutions Holding DYN
# of Institutions
208Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$119 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$109 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$102 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$101 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$101 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $766M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...